YTE reported $140.84M in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.71M 23.06M
Agenus AGEN:US $ -66.4M 25.02M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Amgen AMGN:US $ 828M 1301M
Biocryst Pharmaceuticals BCRX:US $ -29.58M 21.8M
Biogen BIIB:US $ 485.7M 488.2M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Bristol Myers Squibb BMY:US $ 1715M 36M
Cerulean Pharma CERU:US $ -9162930 1.84M
Chemocentryx CCXI:US $ -38.74M 9.41M
Clovis Oncology CLVS:US $ -57.58M 0.43M
Cti Biopharma CTIC:US $ -19.51M 2.44M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Exelixis EXEL:US $ 123.01M 127.62M
Gilead Sciences GILD:US $ 2246M 644M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Idera Pharmaceuticals IDRA:US $ -7.56M 2.47M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 1497M 1517M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Moderna Inc MRNA:US 3.06B 1.8B
Nektar Therapeutics NKTR:US $ -110.2M 0.81M
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Newlink Genetics NLNK:US -8664000 47K
Novartis NOVN:VX 3.48B 1.06B
Novartis NVS:US $ 3479M 1064M
Pfizer PFE:US $ 5914M 397M
Ptc Therapeutics PTCT:US $ -98.49M 0.34M
Puma Biotechnology PBYI:US $ -1.73M 21.69M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Seattle Genetics SGEN:US $ -89.6M 32.82M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
YTE INCY:US $ 140.84M 42.04M